Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Merck Sharp & Dohme Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (146)
Australian public assessment report (AusPar) (4)

Date

2018 (1)
2017 (13)
2016 (38)
2015 (87)
2014 (11)

Search

Sponsor content

150 result(s) found, displaying 41 to 50

PEG-INTRON CLEARCLICK INJECTOR peginterferon alfa-2b (rbe) 100 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under S30(1)

1 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON CLEARCLICK INJECTOR peginterferon alfa-2b (rbe) 120 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under S30(1)

1 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON CLEARCLICK INJECTOR peginterferon alfa-2b (rbe) 150 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under S30(1)

1 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
CLARADERM alclometasone dipropionate 0.5mg/g ointment tube Cancelled under S30(1)

21 November 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PUREGON follitropin beta 50IU/0.5mL solution for injection vial Cancelled under S30(1)

21 November 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PUREGON follitropin beta 100IU/0.5mL solution for injection vial Cancelled under S30(1)

21 November 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PUREGON follitropin beta 150IU/0.5mL solution for injection vial Cancelled under S30(1)

21 November 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PRINIVIL 5 Lisinopril 5mg tablet blister pack Cancelled under S30(1)

16 September 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PRINIVIL 10 Lisinopril 10mg tablet blister pack Cancelled under S30(1)

16 September 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PRINIVIL 20 Lisinopril 20mg tablet blister pack Cancelled under S30(1)

16 September 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.